CNS Lymphoma
Lymphoma Relapse Risk Lower with Autologous HSCT Than Radiotherapy
Cecilia BrownTransplantation & Cellular Therapy | November 22, 2022
Patients with newly diagnosed primary central nervous system lymphoma who received high-dose chemotherapy and autologous ...
Read More
Circulating Tumor DNA Could Be a New Noninvasive Tool for CNS Lymphoma Prediction
Brandon MayAggressive B-Cell Lymphoma | November 14, 2022
Circulating tumor DNA accurately reflects tumor burden and may serve as a useful clinical biomarker for risk and outcome in ...
Read More
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |